The orthopedic biomaterials have garnered $14.2 billion revenue in 2021, and it is projected to rise at the rate of 9.5% from 2021 to 2030, to generate $32.2 billion revenue in 2030. The reconstructive joint replacements category holds the largest industry share, rising at a rate of 9.2% in the near future, to generate $4.02 billion revenue in 2030. It is ascribed to the rising incidence of late-stage and joint damage osteoarthritis.

Moreover, the rising demand for custom-made next-generation orthopedic biomaterials that suits the requirement of a specific operation, has resulted in industry propulsion. Concerning this, the growing incidence of orthopedic operations, including viscosupplementation, joint arthroplasty, and joint reconstruction results in industry expansion.

The hospitals category capture the largest industry share, of approx. 41.7% in the worldwide major countries. It is ascribed to the rising number of hospital admissions, and increasing patient footfall for orthopedic procedures.

Patients usually prefer to be treated at hospitals, due to the accessibility of modern therapeutic and diagnostic methods, without admitting to the hospital.

The non-metal category, including polymers and ceramic capture a substantial industry share, of 59.7%, and it is projected to experience faster growth, of 9.9% in the coming years. It is led by growing hard tissue restoration application of ceramics in numerous procedures, and wide usage of polymers as bone cement and load-bearing surfaces in total joint arthroplasties.

Furthermore, an increasing incidence of interbody fusion procedures and spine surgeries will fuel the requirement for non-metallic orthopedic biomaterials in the near future. The increasing usage of pedicle screws and synthetic cages in fixation operations boosts the orthopedic biomaterials industry growth.

These products are increasingly used to propel the allografts' fusion rate. Moreover, the accessibility of sophisticated traditional biopolymers for various applications, including orthobiologic tissue fixation, and bio-resorabable has fuelled the demand for polymer worldwide.

The orthobiologics category is projected to experience the fastest growth in the coming years, ascribing to the rising number of bone repair, and reconstruction procedures worldwide, which results in the growing prevalence of trauma and obesity.

Around one million people succumb to death worldwide each year due to road accidents. This accounts for 90% of the deaths in low- and middle-income countries.

The surging musculoskeletal problems are projected to fuel the orthopedic biomaterials industry growth. The worldwide major cause of disability is musculoskeletal diseases. Around 20% to 30% of the population suffer from these disabilities.


Orthopedic Biomaterials Market Growth Analysis Report@ https://www.psmarketresearch.com/market-analysis/orthopedic-biomaterials-market